| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,477 |
6,895 |
$807K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,887 |
9,280 |
$773K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,077 |
3,077 |
$283K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,361 |
6,337 |
$253K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,583 |
2,413 |
$226K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,509 |
1,509 |
$137K |
| 92587 |
|
2,913 |
2,910 |
$56K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
635 |
612 |
$53K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
762 |
762 |
$46K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,318 |
1,276 |
$41K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,034 |
997 |
$38K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
684 |
660 |
$34K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,190 |
2,096 |
$32K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
303 |
303 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,046 |
1,010 |
$29K |
| 87634 |
|
379 |
365 |
$24K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,378 |
1,378 |
$12K |
| 80061 |
Lipid panel |
843 |
843 |
$10K |
| 99381 |
|
97 |
97 |
$9K |
| 99173 |
|
3,428 |
3,427 |
$9K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
321 |
315 |
$6K |
| 83655 |
|
559 |
558 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
124 |
116 |
$6K |
| 99383 |
|
55 |
55 |
$6K |
| 96161 |
|
882 |
880 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
28 |
28 |
$4K |
| 87807 |
|
306 |
289 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25 |
25 |
$2K |
| 85018 |
|
709 |
709 |
$1K |
| 99382 |
|
12 |
12 |
$1K |
| 96127 |
|
76 |
76 |
$346.24 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
30 |
26 |
$226.80 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
28 |
26 |
$62.72 |
| 90633 |
|
814 |
814 |
$3.00 |
| 90723 |
|
1,442 |
1,440 |
$1.46 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
32 |
28 |
$1.32 |
| 90710 |
|
456 |
456 |
$1.04 |
| 90680 |
|
972 |
970 |
$0.36 |
| 90696 |
|
166 |
166 |
$0.28 |
| 90686 |
|
1,814 |
1,814 |
$0.15 |
| 90651 |
|
158 |
158 |
$0.00 |
| 90647 |
|
861 |
860 |
$0.00 |
| 90619 |
|
31 |
31 |
$0.00 |
| 90716 |
|
93 |
93 |
$0.00 |
| 90677 |
|
247 |
247 |
$0.00 |
| 90656 |
|
56 |
56 |
$0.00 |
| 90670 |
|
1,238 |
1,236 |
$0.00 |
| 90648 |
|
243 |
243 |
$0.00 |
| 90700 |
|
122 |
122 |
$0.00 |
| 96160 |
|
2,522 |
2,522 |
$0.00 |
| 90707 |
|
26 |
26 |
$0.00 |
| 90734 |
|
66 |
66 |
$0.00 |
| 90715 |
|
46 |
46 |
$0.00 |